Corinne Vandermeulen

Author

KU Leuven ORCID

Also Known As

C Vandermeulen, C. Vandermeulen, C. Vanderrneulen, Corinne Vandermeulen, VANDERMEULEN C, Vandermeulen Corinne

141

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

KU Leuven University of Antwerp Ghent University Hospital GlaxoSmithKline (Belgium)Rega Institute for Medical Research

About

Corinne Vandermeulen is an author at KU Leuven specializing in vaccination, medicine, and vaccine safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	882
2	Epidemiology	12	12	567
3	Public Health	10	10	577
4	Allergy	3	3	93
5	Cell Biology	1	1	16

Corinne Vandermeulen

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults Étienne Sokal, Karel Hoppenbrouwers, Corinne Vandermeulen, The Journal of Infectious Diseases	2007	413
Sexual maturation in relation to polychlorinated aromatic hydrocarbons: Sharpe and Skakkebaek's hypothesis revisited. Elly Den Hond, Harry A. Roels, Karel Hoppenbrouwers, Environmental Health Perspectives	2002	224
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate Lorena Sánchez-Felipe, Thomas Vercruysse, Sapna Sharma, Nature	2020	184
Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Corinne Vandermeulen, Mathieu Roelants, Marijke Vermoere, Vaccine VaccinologyVaccine SafetyVaccinationVaccinated Child PopulationVaccine Development	2004	124
An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults Karin Levie, Isabel Leroux‐Roels, Karel Hoppenbrouwers, The Journal of Infectious Diseases	2008	117
Influenza and pertussis vaccination coverage in pregnant women Jolien Laenen, Mathieu Roelants, Roland Devlieger, Vaccine VaccinationPertussis Vaccination CoverageMaternal ImmunizationPregnancyMaternal Health	2015	113
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial Isabel Leroux‐Roels, Matthew Davis, Katie Steenackers, The Journal of Infectious Diseases	2022	109
The Value of CAGE, CUGE, and AUDIT in Screening for Alcohol Abuse and Dependence Among College Freshmen B. Aertgeerts, F. Buntinx, J. Bande-Knops, Alcoholism Clinical and Experimental Research	2000	102
Attitudes, believes, determinants and organisational barriers behind the low seasonal influenza vaccination uptake in healthcare workers – A cross-sectional survey Lise Boey, Charlotte Bral, Mathieu Roelants, Vaccine VaccinationPreventive MedicineOrganisational BarriersVaccine EfficacyInfluenza Vaccine	2018	97
Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen, Clinical Pharmacology & Therapeutics	2017	95

Page 1